Salvador-Morales Carolina, Valencia Pedro M, Thakkar Anjali B, Swanson Edward W, Langer Robert
Harvard-MIT Center of Cancer Nanotechnology Excellence, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
Front Biosci (Elite Ed). 2012 Jan 1;4(1):529-45. doi: 10.2741/e398.
Multifunctional hybrid nanoparticles combine some of the unique physical and chemical characteristics of two or more classes of materials, such as polymers, liposomes, metals, quantum dots and mesoporous silica among others, to create a versatile and robust new class of nanoparticles. Here we discuss the most recent synthetic strategies to create these hybrid systems and analyze four key design aspects: stability, encapsulation of therapeutic and imaging agents, controlled release of encapsulated agents, and biocompatibility. Through the combination of multiple nanomaterials, hybrid nanoparticles aim to expand the functionality of single-component systems, using the strengths of one material to improve on weaknesses of another. We then examine how hybrid nanoparticle platforms provide unique opportunities in cancer therapy, specifically in the treatment of multidrug resistant cancer. Finally, we discuss some of the challenges hybrid nanoparticles systems might face in their large scale synthesis and commercialization in the biopharmaceutical industry.
多功能杂化纳米粒子结合了两类或更多类材料(如聚合物、脂质体、金属、量子点和介孔二氧化硅等)的一些独特物理和化学特性,以创建一类通用且强大的新型纳米粒子。在此,我们讨论创建这些杂化系统的最新合成策略,并分析四个关键设计方面:稳定性、治疗和成像剂的封装、封装剂的控释以及生物相容性。通过多种纳米材料的组合,杂化纳米粒子旨在利用一种材料的优势改善另一种材料的劣势,从而扩展单一组分系统的功能。然后,我们研究杂化纳米粒子平台如何在癌症治疗,特别是多药耐药癌症的治疗中提供独特机遇。最后,我们讨论杂化纳米粒子系统在生物制药行业大规模合成和商业化过程中可能面临的一些挑战。